Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer

Background: In a European cohort, it was previously reported that 35% of oropharyngeal cancer (OPC) patients were human papillomavirus type-16 (HPV16) seropositive up to 10 years before diagnosis vs 0.6% of cancer-free controls. Here, we describe the kinetics of HPV16-E6 antibodies prior to OPC diag...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Natl Cancer Inst
Main Authors: Kreimer, Aimée R., Johansson, Mattias, Yanik, Elizabeth L., Katki, Hormuzd A., Check, David P., Lang Kuhs, Krystle A., Willhauck-Fleckenstein, Martina, Holzinger, Dana, Hildesheim, Allan, Pfeiffer, Ruth, Williams, Craig, Freedman, Neal D., Huang, Wen-Yi, Purdue, Mark P., Michel, Angelika, Pawlita, Michael, Brennan, Paul, Waterboer, Tim
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5967352/
https://ncbi.nlm.nih.gov/pubmed/28376197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djx005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados